ACE2 and COVID-19: ACEI and ARB treatment can increase ACE2 expression in animal-based studies.7,8 Potentially, ACEI/ARB might increase ACE2 expression, thus promoting SARS-COV-2 susceptibility and disease severity of COVID-19.